Key result
Heme oxygenase-1 and carbon monoxide drive angiogenesis, mediating the effects of VEGF and SDF-1.
Heme oxygenase-1 and its product carbon monoxide are important mediators of angiogenesis and represent potential therapeutic targets for vascular and ischemic conditions.
Angiogenesis involves the formation of new blood vessels and is critical for fundamental events such as development and repair after injury. Perturbances in angiogenesis contribute to the pathogenesis of diverse clinical conditions including cancer, complications of diabetes mellitus, ischemia/reperfusion injury of the heart and other organs, and preeclampsia, as well as a number of inflammatory disorders. Recent work has identified heme oxygenase-1 and its gaseous product, carbon monoxide, to possess potent proangiogenic properties in addition to well-recognized antiinflammatory, antioxidant, and antiapoptotic effects. Angiogenic factors, such as vascular endothelial growth factor and stromal cell-derived factor-1, mediate their proangiogenic effects through induction of heme oxygenase-1, making it an attractive target for therapeutic intervention. This review will provide an overview of the role of heme oxygenase-1 and carbon monoxide in angiogenesis.
No takes yet. Share an insight, caveat, or question.
Dulak et al. (2008) conducted a review in Vascular Pathobiology / Angiogenesis. Heme oxygenase-1 and carbon monoxide was evaluated. Heme oxygenase-1 and its gaseous product, carbon monoxide, possess potent proangiogenic properties and mediate the effects of angiogenic factors like VEGF and SDF-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: